Recently, Peng and his colleagues have shown that over-expression of the murine chemokine receptor CXCR2 on T cells improves their homing to melanoma and tumor regression in mice model [84], suggesting that endowing T cells with improved chemotaxis capabilities to tumor sites may also enhance ACT. Here, CXCR2 is linked to neoplasm.